OBJECTIVE: To determine if serum urate concentration is associated with development of hypertension in young adults. METHODS: Retrospective cohort analysis from 4752 participants with available serum urate and without hypertension at baseline from the Coronary Artery Risk Development in Young Adults (CARDIA) study; a mixed race (African-American and White) cohort established in 1985 with 20 years of follow-up data for this analysis. Associations between baseline serum urate concentration and incident hypertension (defined as a blood pressure greater or equal to 140/90 or being on antihypertensive drugs) were investigated in sex-stratified bivariate and multivariable Cox-proportional analyses. RESULTS: Mean age (SD) at baseline was 24.8 (3.6) years for men and 24.9 (3.7) years for women. Compared with the referent category, we found a greater hazard of developing hypertension starting at 345 µmol/l (5.8 mg/dl) of serum urate for men and 214 µmol/l (3.6 mg/dl) for women. There was a 25% increase in the hazard of developing hypertension in men (HR1.25 (95% CI 1.15 to 1.36)) per each mg/dl increase in serum urate but no significant increase in women (HR 1.06 (95%CI 0.97 to 1.16)). CONCLUSIONS: We found a significant independent association between higher serum urate concentrations and the subsequent hazard of incident hypertension, even at concentrations below the conventional hyperuricaemia threshold of 404 µmol/l (6.8 mg/dl).
OBJECTIVE: To determine if serum urate concentration is associated with development of hypertension in young adults. METHODS: Retrospective cohort analysis from 4752 participants with available serum urate and without hypertension at baseline from the Coronary Artery Risk Development in Young Adults (CARDIA) study; a mixed race (African-American and White) cohort established in 1985 with 20 years of follow-up data for this analysis. Associations between baseline serum urate concentration and incident hypertension (defined as a blood pressure greater or equal to 140/90 or being on antihypertensive drugs) were investigated in sex-stratified bivariate and multivariable Cox-proportional analyses. RESULTS: Mean age (SD) at baseline was 24.8 (3.6) years for men and 24.9 (3.7) years for women. Compared with the referent category, we found a greater hazard of developing hypertension starting at 345 µmol/l (5.8 mg/dl) of serum urate for men and 214 µmol/l (3.6 mg/dl) for women. There was a 25% increase in the hazard of developing hypertension in men (HR1.25 (95% CI 1.15 to 1.36)) per each mg/dl increase in serum urate but no significant increase in women (HR 1.06 (95%CI 0.97 to 1.16)). CONCLUSIONS: We found a significant independent association between higher serum urate concentrations and the subsequent hazard of incident hypertension, even at concentrations below the conventional hyperuricaemia threshold of 404 µmol/l (6.8 mg/dl).
Entities:
Keywords:
Arterial Hypertension; Epidemiology; Health services research
Authors: Philip B Mellen; Anthony J Bleyer; Thomas P Erlinger; Gregory W Evans; F Javier Nieto; Lynne E Wagenknecht; Marion R Wofford; David M Herrington Journal: Hypertension Date: 2006-10-23 Impact factor: 10.190
Authors: Todd S Perlstein; Olga Gumieniak; Gordon H Williams; David Sparrow; Pantel S Vokonas; Michael Gaziano; Scott T Weiss; Augusto A Litonjua Journal: Hypertension Date: 2006-10-23 Impact factor: 10.190
Authors: Lisa Stamp; Leah Ha; Martin Searle; John O'Donnell; Chris Frampton; Peter Chapman Journal: Nephrology (Carlton) Date: 2006-08 Impact factor: 2.506
Authors: Atsushi Hozawa; David R Jacobs; Michael W Steffes; Myron D Gross; Lyn M Steffen; Duk-Hee Lee Journal: Clin Chem Date: 2007-01-18 Impact factor: 8.327
Authors: V F Panoulas; K M J Douglas; H J Milionis; P Nightingale; M D Kita; R Klocke; G S Metsios; A Stavropoulos-Kalinoglou; M S Elisaf; G D Kitas Journal: J Hum Hypertens Date: 2007-10-25 Impact factor: 3.012
Authors: Michael B Saddekni; Kenneth G Saag; Tanja Dudenbostel; Suzanne Oparil; David A Calhoun; Sebastian E Sattui; Daniel I Feig; Paul Muntner; David T Redden; Phillip J Foster; Elizabeth J Rahn; Stephanie R Biggers; Peng Li; Angelo L Gaffo Journal: Contemp Clin Trials Date: 2016-08-30 Impact factor: 2.226
Authors: Pascal Richette; Fernando Perez-Ruiz; Michael Doherty; Tim L Jansen; George Nuki; Eliseo Pascual; Leonardo Punzi; Alexander K So; Thomas Bardin Journal: Nat Rev Rheumatol Date: 2014-08-19 Impact factor: 20.543
Authors: Ninad S Chaudhary; S Louis Bridges; Kenneth G Saag; Elizabeth J Rahn; Jeffrey R Curtis; Angelo Gaffo; Nita A Limdi; Emily B Levitan; Jasvinder A Singh; Lisandro D Colantonio; George Howard; Mary Cushman; Matthew L Flaherty; Suzanne Judd; Marguerite R Irvin; Richard J Reynolds Journal: Hypertension Date: 2019-12-02 Impact factor: 10.190